Luminex Corporation expects 2020 consolidated revenue to be between $352 and $362 million, up approximately 7% to the mid-point relative to 2019, which includes approximately 2% to 3% headwind attributable to the departure of certain remaining sales to LabCorp.

The company anticipates being profitable in the fourth quarter of 2019.

The company reported revenue results for the fourth quarter and full year of 2019. The company reported total fourth quarter revenue of $90.4 million, an 11% increase over fourth quarter of 2018.

Total full year revenue of $334.6 million, up 6%; and up 19% without consideration of LabCorp revenue and including the effect of the Flow Cytometry acquisition. Sample-to-answer full year revenue was $75.7 million, up more than 20% against 2018, including contracting 200 additional systems.